Cargando…
Overexpression of P-glycoprotein, MRP2, and CYP3A4 impairs intestinal absorption of octreotide in rats with portal hypertension
BACKGROUND: Portal hypertension (PH) is the main cause of complications and death in liver cirrhosis. The effect of oral administration of octreotide (OCT), a drug that reduces PH by the constriction of mesenteric arteries, is limited by a remarkable intestinal first-pass elimination. METHODS: The b...
Autores principales: | Sun, Xiaoyu, Tang, Shunxiong, Hou, Binbin, Duan, Zhijun, Liu, Zhen, Li, Yang, He, Shoucheng, Wang, Qiuming, Chang, Qingyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789354/ https://www.ncbi.nlm.nih.gov/pubmed/33407159 http://dx.doi.org/10.1186/s12876-020-01532-4 |
Ejemplares similares
-
A Novel Perspective and Approach to Intestinal Octreotide Absorption: Sinomenine-Mediated Reversible Tight Junction Opening and Its Molecular Mechanism
por: Li, Yuling, et al.
Publicado: (2013) -
Inhibition of P-glycoprotein, multidrug resistance-associated protein 2 and cytochrome P450 3A4 improves the oral absorption of octreotide in rats with portal hypertension
por: Sun, Xiao-Yu, et al.
Publicado: (2022) -
Effects of a Long-Acting Formulation of Octreotide on Patients with Portal Hypertension
por: Cui, Pei-Jing, et al.
Publicado: (2017) -
Preparation of long-acting microspheres loaded with octreotide for the treatment of portal hypertensive
por: Han, Bing, et al.
Publicado: (2021) -
Characterization of SN38-resistant T47D breast cancer cell sublines overexpressing BCRP, MRP1, MRP2, MRP3, and MRP4
por: Lee, Hee-Jeong, et al.
Publicado: (2022)